Opyl Ltd (OPL) - Total Liabilities
Based on the latest financial reports, Opyl Ltd (OPL) has total liabilities worth AU$695.82K AUD (≈ $492.33K USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore OPL cash flow metrics to assess how effectively this company generates cash.
Opyl Ltd - Total Liabilities Trend (1996–2024)
This chart illustrates how Opyl Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Opyl Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Opyl Ltd Competitors by Total Liabilities
The table below lists competitors of Opyl Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sawang Export Public Company Limited
BK:SAWANG
|
Thailand | ฿29.78 Million |
|
Ashoka India Equity Investment Trust PLC
LSE:AIE
|
UK | GBX34.40 Million |
|
RPM Automotive Group Ltd
AU:RPM
|
Australia | AU$57.30 Million |
|
Kingsland Minerals Ltd
AU:KNG
|
Australia | AU$468.88K |
|
Sonetel AB
ST:SONE
|
Sweden | Skr12.75 Million |
|
Lottery.com Inc.
NASDAQ:SEGG
|
USA | $29.95 Million |
Liability Composition Analysis (1996–2024)
This chart breaks down Opyl Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see OPL company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.47 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.81 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Opyl Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Opyl Ltd (1996–2024)
The table below shows the annual total liabilities of Opyl Ltd from 1996 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | AU$501.76K ≈ $355.03K |
-54.93% |
| 2023-06-30 | AU$1.11 Million ≈ $787.64K |
+56.30% |
| 2022-06-30 | AU$712.21K ≈ $503.93K |
+126.28% |
| 2021-06-30 | AU$314.75K ≈ $222.71K |
+45.32% |
| 2020-06-30 | AU$216.59K ≈ $153.25K |
-70.45% |
| 2019-06-30 | AU$732.96K ≈ $518.62K |
+14.60% |
| 2018-06-30 | AU$639.61K ≈ $452.56K |
+60.72% |
| 2017-06-30 | AU$397.95K ≈ $281.58K |
+79.49% |
| 2016-06-30 | AU$221.72K ≈ $156.88K |
+804.34% |
| 2015-06-30 | AU$24.52K ≈ $17.35K |
-85.28% |
| 2014-06-30 | AU$166.55K ≈ $117.84K |
-44.00% |
| 2013-06-30 | AU$297.38K ≈ $210.42K |
+95.42% |
| 2012-06-30 | AU$152.18K ≈ $107.68K |
-90.00% |
| 2011-06-30 | AU$1.52 Million ≈ $1.08 Million |
+7199.87% |
| 2010-06-30 | AU$20.85K ≈ $14.75K |
-99.53% |
| 2009-06-30 | AU$4.45 Million ≈ $3.15 Million |
-81.74% |
| 2008-06-30 | AU$24.38 Million ≈ $17.25 Million |
+18.47% |
| 2007-06-30 | AU$20.58 Million ≈ $14.56 Million |
+1108.46% |
| 2006-06-30 | AU$1.70 Million ≈ $1.20 Million |
+24.90% |
| 2005-06-30 | AU$1.36 Million ≈ $964.78K |
-46.57% |
| 2004-06-30 | AU$2.55 Million ≈ $1.81 Million |
+621.04% |
| 2003-06-30 | AU$353.95K ≈ $250.44K |
-29.06% |
| 2002-06-30 | AU$498.97K ≈ $353.05K |
-29.94% |
| 2001-06-30 | AU$712.21K ≈ $503.93K |
+178.86% |
| 2000-06-30 | AU$255.40K ≈ $180.71K |
-63.51% |
| 1999-06-30 | AU$700.01K ≈ $495.30K |
+745.31% |
| 1998-06-30 | AU$82.81K ≈ $58.59K |
-48.73% |
| 1997-06-30 | AU$161.53K ≈ $114.29K |
-74.01% |
| 1996-06-30 | AU$621.55K ≈ $439.79K |
-- |
About Opyl Ltd
Pathkey.AI Ltd engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool strea… Read more